Saltar al contenido
Merck

Pyrazinamide resistance and pncA gene mutations in Mycobacterium tuberculosis.

Antimicrobial agents and chemotherapy (2008-03-05)
Pontus Juréen, Jim Werngren, Juan-Carlos Toro, Sven Hoffner
RESUMEN

Thirty-four pyrazinamide-resistant and 37 pyrazinamide-susceptible Mycobacterium tuberculosis complex strains were analyzed for pncA gene mutations. None of the sensitive strains had any mutations, apart from silent mutations, whereas all but one resistant strain showed pncA mutations. By using sequencing as a means of early resistance detection, the inconsistency of phenotypic pyrazinamide assays can be circumvented.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Pyrazinecarboxamide